Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists (Q36246140)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

based on heuristic

inferred from title

author name string

Gulen Hatemi

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Melike Melikoglu

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Fatma Ozbakir

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Koray Tascilar

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Hasan Yazici

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

18 June 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Arthritis Research and Therapy

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

R147

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

https://scigraph.springernature.com/pub.10.1186/ar3882

0 references

Challenges in diagnosing latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

1 October 2017

How tumour necrosis factor blockers interfere with tuberculosis immunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

1 October 2017

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

1 October 2017

Screening for tuberculosis infection prior to initiation of anti-TNF therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

1 October 2017

Interferon-gamma release assay for the diagnosis of latent TB infection--analysis of discordant results, when compared to the tuberculin skin test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

1 October 2017

Reproducibility of QuantiFERON-TB gold in-tube assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

1 October 2017

Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

1 October 2017

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

1 October 2017

Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

1 October 2017

Clinical pharmacokinetics of TNF antagonists: how do they differ?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

1 October 2017

Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

29 June 2018

French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

29 June 2018

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

1 reference

https://api.crossref.org/works/10.1186%2FAR3882

21 January 2018

Development of leprosy in a patient with ankylosing spondylitis during the infliximab treatment: reactivation of a latent infection?

1 reference

https://api.crossref.org/works/10.1186%2FAR3882

21 January 2018

Highly discordant T cell responses in individuals with recent exposure to household tuberculosis

1 reference

https://api.crossref.org/works/10.1186%2FAR3882

21 January 2018

Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis.

1 reference

https://api.crossref.org/works/10.1186%2FAR3882

21 January 2018

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

https://api.crossref.org/works/10.1186%2FAR3882

21 January 2018

Comparison of the tuberculin skin test and the quantiferon test for latent Mycobacterium tuberculosis infections in health care workers in Turkey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

22 September 2018

Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

22 September 2018

Infliximab does not suppress the tuberculin skin test (purified protein derivative).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

22 September 2018

Comparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

22 September 2018

Tuberculosis associated with blocking agents against tumor necrosis factor-alpha--California, 2002-2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

22 September 2018

Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1186%2FAR3882

21 January 2018

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446532

5 December 2018

A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced production of interferon alpha and interferon gamma in leukocyte cultures from patients with active rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired mitogen-induced interferon-gamma production in rheumatoid arthritis and related diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Guidelines of the Israeli association of rheumatology for the prevention of tuberculosis in patients treated with TNF-alpha blockers]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comment on: Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type I reaction of Hansen's disease with exposure to adalimumab: a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22709461

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36246140&oldid=1993881904"